Literature DB >> 23399912

Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.

G Drui1, S Carnicella1, C Carcenac1, M Favier1, A Bertrand1, S Boulet1, M Savasta2.   

Abstract

Parkinson's disease (PD) involves the degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) that is thought to cause the classical motor symptoms of this disease. However, motivational and affective impairments are also often observed in PD patients. These are usually attributed to a psychological reaction to the general motor impairment and to a loss of some of the neurons within the ventral tegmental area (VTA). We induced selective lesions of the VTA and SNc DA neurons that did not provoke motor deficits, and showed that bilateral dopamine loss within the SNc, but not within the VTA, induces motivational deficits and affective impairments that mimicked the symptoms of PD patients. Thus, motivational and affective deficits are a core impairment of PD, as they stem from the loss of the major group of neurons that degenerates in this disease (DA SNc neurons) and are independent of motor deficits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399912      PMCID: PMC5116056          DOI: 10.1038/mp.2013.3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  46 in total

Review 1.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

Review 2.  The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

Authors:  P Sokoloff; J Diaz; B Le Foll; O Guillin; L Leriche; E Bezard; C Gross
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-02       Impact factor: 4.388

Review 3.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

Review 4.  SSRI-induced apathy syndrome: a clinical review.

Authors:  W Jason Barnhart; Eugene H Makela; Melissa J Latocha
Journal:  J Psychiatr Pract       Date:  2004-05       Impact factor: 1.325

5.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.

Authors:  M Olsson; G Nikkhah; C Bentlage; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 6.  Neurotransmission in Parkinson's disease: beyond dopamine.

Authors:  P Barone
Journal:  Eur J Neurol       Date:  2009-12-30       Impact factor: 6.089

7.  GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.

Authors:  Sebastien Carnicella; Viktor Kharazia; Jerome Jeanblanc; Patricia H Janak; Dorit Ron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-09       Impact factor: 11.205

Review 8.  Apathy: a neuropsychiatric syndrome.

Authors:  R S Marin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

9.  Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.

Authors:  Virginie Czernecki; Michael Schüpbach; Sadek Yaici; Richard Lévy; Eric Bardinet; Jérôme Yelnik; Bruno Dubois; Yves Agid
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

10.  Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease.

Authors:  Faustine Lelan; Cécile Boyer; Reynald Thinard; Séverine Rémy; Claire Usal; Laurent Tesson; Ignacio Anegon; Isabelle Neveu; Philippe Damier; Philippe Naveilhan; Laurent Lescaudron
Journal:  Parkinsons Dis       Date:  2011-06-28
View more
  48 in total

1.  Dopamine neuron dependent behaviors mediated by glutamate cotransmission.

Authors:  Susana Mingote; Nao Chuhma; Abigail Kalmbach; Gretchen M Thomsen; Yvonne Wang; Andra Mihali; Caroline Sferrazza; Ilana Zucker-Scharff; Anna-Claire Siena; Martha G Welch; José Lizardi-Ortiz; David Sulzer; Holly Moore; Inna Gaisler-Salomon; Stephen Rayport
Journal:  Elife       Date:  2017-07-13       Impact factor: 8.140

Review 2.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

3.  Neurotensin Receptor-1 Identifies a Subset of Ventral Tegmental Dopamine Neurons that Coordinates Energy Balance.

Authors:  Hillary L Woodworth; Hannah M Batchelor; Bethany G Beekly; Raluca Bugescu; Juliette A Brown; Gizem Kurt; Patrick M Fuller; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

4.  New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Authors:  Michael A Kelberman; Elena M Vazey
Journal:  Curr Pharmacol Rep       Date:  2016-09-28

Review 5.  Lewy Body Degenerations as Neuropsychiatric Disorders.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

6.  Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease.

Authors:  David Mallet; Raphael Goutaudier; Emmanuel L Barbier; Sebastien Carnicella; Jerry R Colca; Florence Fauvelle; Sabrina Boulet
Journal:  Mol Neurobiol       Date:  2022-07-27       Impact factor: 5.682

7.  Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion.

Authors:  Anton Ilango; Andrew J Kesner; Kristine L Keller; Garret D Stuber; Antonello Bonci; Satoshi Ikemoto
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 8.  Neural substrates underlying effort, time, and risk-based decision making in motivated behavior.

Authors:  Matthew R Bailey; Eleanor H Simpson; Peter D Balsam
Journal:  Neurobiol Learn Mem       Date:  2016-07-15       Impact factor: 2.877

9.  Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.

Authors:  Jared T Hinkle; Kelly A Mills; Kate Perepezko; Gregory M Pontone
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-02-24       Impact factor: 2.680

10.  Leptin Receptor Expressing Neurons in the Substantia Nigra Regulate Locomotion, and in The Ventral Tegmental Area Motivation and Feeding.

Authors:  Véronne A J de Vrind; Lisanne J van 't Sant; Annemieke Rozeboom; Mieneke C M Luijendijk-Berg; Azar Omrani; Roger A H Adan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.